Ventio

Deutsch

NBIA, oral comm, Assises de génétique, 2026

Quantification of magnetic susceptibility to assess intracerebral iron levels: towards a biomarker for monitoring the progression of intracerebral iron accumulation in NBIA? Chloé Angelini (1, 2) , Cyril Goizet (3, 2) , Patricia Fergelot (1, 2) , Ludovic de Rochefort … Read More

Auf der VivaTech präsentiert Ventio eine bahnbrechende Innovation aus dem Programm France 2030 zur Transformation der Gehirnbildgebung und der Diagnose neurodegenerativer Erkrankungen

Marseille, June 2026 – After two years of R&D supported by the France 2030 investment programme – Artificial Intelligence – Medical Imaging – Région Sud, the Marseille-based startup Ventio has reached a major milestone in its development with the filing … Read More

Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple Sclerosis

Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple Sclerosis NMR in Biomedicine, 2026, 39 (6) Benjamin Streichenberger (1) , Mathieu Santin (2) , Ludovic de Rochefort (3) , Quentin Duché (4) , Catherine Guillemot (5), Samira Mchinda (3) , Stéphane Roche (3) , Anne Kerbrat (1, 6) , Elise Bannier (1, … Read More

Invitation: “Around BPAN”

Ventio has been invited to present its findings to clinicians and researchers working on rare diseases Neurodegenerescence with Brain Iron Accumulation (NBIA). You can find the announcement for this symposium and the program here!  Friday, june 5th 8h45 – 9h15 … Read More

CIC Innovation Awards: “Disruptive Innovation” Category

Following last week’s “Favorite” award at TDH2026, the momentum continues at Ventio! 🙏 We are thrilled to have won the Disruptive Innovation Award at the CIC Start Innovation Awards! 🎉 Thank you to the jury for their support! We accept … Read More

„Jury’s Choice“ award at the 2026 Hypergrowth Awards – TDH2026

We are honoured and proud to have been awarded the „Jury’s choice“ prize last Thursday at the Hypergrowth Awards. 🙏 This recognition means a great deal to us and serves as a tribute to the hard work, dedication and vision of … Read More

Feasibility and Potential of Quantitative Susceptibility Mapping in Neurodegeneration with Brain Iron Accumulation (NBIA) at Clinical Magnetic Field

Feasibility and Potential of Quantitative Susceptibility Mapping in Neurodegeneration with Brain Iron Accumulation (NBIA) at Clinical Magnetic Field European Society for Magnetic Resonance in Medicine and Biology, 41st annual scientific meeting; MR to the limits and beyond, Oct 2025, Marseille, … Read More

BIaaS : Ventio revolutionize the diagnosis of neurodegenerative diseases

Our mission: to better understand, diagnose earlier, and accurately monitor neurodegenerative diseases by tracking brain iron. To achieve this mission, we have taken three major steps: ✅ A partnership to strengthen understanding of these diseasesLaunch of the QSM for Alzheimer’s Disease … Read More

Cloud and sensitive information systems: ANSSI recommendations

Whether for profit, espionage or destabilization, attackers‘ growing mastery of cloud environments is leading to an increase in attack attempts. Whether an organization wants to migrate to the cloud, or is already using it, it needs to be aware of … Read More

Samira

Samira MCHINDA PhD

As a research Scientist at Ventio, Samira holds a PhD in neuroscience and medical imaging (ORCID). She is involved in research, development and innovation projects within the company.